Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Tyra Biosciences, Inc. (TYRA) had Stock-Based Compensation of $28.01M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-119.95M |
|
-- |
|
-- |
|
$132.76M |
|
$-132.76M |
|
$12.81M |
|
$-119.95M |
|
$-119.95M |
|
$-119.95M |
|
$-119.95M |
|
$-119.95M |
|
$-119.95M |
|
$-132.76M |
|
$-132.22M |
|
59.60M |
|
59.60M |
|
$-2.01 |
|
$-2.01 |
|
| Balance Sheet Financials | |
$265.45M |
|
$1.31M |
|
$17.16M |
|
$282.61M |
|
$18.09M |
|
-- |
|
$5.34M |
|
$23.43M |
|
$259.18M |
|
$259.18M |
|
$259.18M |
|
53.71M |
|
| Cash Flow Statement Financials | |
$-95.14M |
|
$72.46M |
|
$8.10M |
|
$92.97M |
|
$78.39M |
|
$-14.58M |
|
|
Stock-Based Compensation |
$28.01M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-95.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.28% |
|
-46.28% |
|
-42.44% |
|
-46.28% |
|
$4.83 |
|
$-1.60 |
|
$-1.60 |
|